A Study in Participants With Diabetic Kidney Disease
A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 417 participants.
Also called NCT01113801
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 417 participants
- Sponsor
- Registry
-
NCT01113801
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Czechia, France, Hungary, Israel, Puerto Rico
- Registry status
- Terminated
Technical summary
Registry record NCT01113801. Randomized; triple masking; primary purpose treatment. Start 2010-07 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2017-12-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study in Participants With Diabetic Kidney Disease
- Condition
- Diabetic Kidney Disease
- Condition
- Diabetic Nephropathy
- Condition
- Diabetic Glomerulosclerosis
- Intervention (Drug)
- LY2382770
- Intervention (Drug)
- Placebo
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01113801- Content hash
5c558504c48e964d49dd729d7d00503cf697c9757c6f3629d93c63c42ab4b1d3